课题基金 / 基金详情

Studies on cytostatic antitumor mechanism by a new PI3K inhibitor ZSTK474

Studies on cytostatic antitumor mechanism by a new PI3K inhibitor ZSTK474
新型PI3K抑制剂ZSTK474的细胞抑制抗肿瘤机制研究
批准号:
20790087
负责人:
DAN Shingo
金额:
$2.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

DAN Shingo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We demonstrated that PI3K inhibitors including ZSTK474 did not induce apoptosis but G_0/G_1 arrest of cell cycle in cancer cell lines with PIK3CA/PTEN aberrations in vitro. In parallel, PI3K inhibitors exhibited their antitumor effect without inducing apoptosis in vivo. We examined gene expression changes after treatment of cancer cells with ZSTK474 by using GeneChip, and found induction of CDK inhibitor p15 and repression of CDC25A after ZSTK474 treatment. These changes would be involved in G_0/G_1 arrest of cell cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ZSTK47, a novel PI3K infibitor, down-regulates CDC25A and induces G1 phase cell cycle arrest in fuman cancer cells.
ZSTK47 是一种新型 PI3K 抑制剂,可下调 CDC25A 并诱导福曼癌细胞 G1 期细胞周期停滞。
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Dan S, Mukai Y, YaguchiS, Yamori T.]
通讯作者: Yamori T.
Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but GO/G1 arrest.
ZSTK474 对 PI3K 的抑制不是通过细胞凋亡而是通过 GO/G1 停滞来抑制肿瘤生长。
DOI: --
发表时间: 2009
期刊: Biochemical and biophysical research communications 379
影响因子: --
作者: [Dan S, Yoshimi H, Okamura M, Mukai Y, Yamori T.]
通讯作者: Yamori T.
Correlation between efficacy of PI3K inhibitors and aberration of PI3K3 CA/PTEN in a panel of 39 human cancer cell lines(JFCR39)
39 种人类癌细胞系 (JFCR39) 中 PI3K 抑制剂的功效与 PI3K3 CA/PTEN 畸变之间的相关性
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Dan S, Sugita H, Seki M, Mukai Y, Yamazaki K, Ishikawa Y, Yamori T.]
通讯作者: Yamori T.
DOI: 10.1016/j.ejca.2010.01.005
发表时间: 2010-04-01
期刊: EUROPEAN JOURNAL OF CANCER
影响因子: 8.4
作者: [Kong, Dexin, Dan, Shingo, Yamori, Takao]
通讯作者: Yamori, Takao
23
    Elucidation of gene dependence of sarcoma cells using functional genomics approach
    • 批准号:
      19H03525
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2019
    • 负责人:
      DAN Shingo
    • 依托单位:
    Development of PI3K pathway activation status and its application for predicting therapeutic efficacies of PI3-kinase inhibitors
    海外基金